Thomas Gajewski to Dacarbazine
This is a "connection" page, showing publications Thomas Gajewski has written about Dacarbazine.
Connection Strength
0.303
-
Temozolomide for melanoma: new toxicities and new opportunities. J Clin Oncol. 2004 Feb 15; 22(4):580-1.
Score: 0.200
-
Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial. JAMA. 2014 Jun 18; 311(23):2397-405.
Score: 0.103